Safeplus Price Earnings Ratio from 2010 to 2024
| BIPH Stock | USD 18.77 0.12 0.64% |
Check Safeplus International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Safeplus International's main balance sheet or income statement drivers, such as , as well as many indicators such as . Safeplus financial statements analysis is a perfect complement when working with Safeplus International Valuation or Volatility modules.
Safeplus |
About Safeplus International Financial Statements
Investors use fundamental indicators, such as Safeplus International's Price Earnings Ratio, to determine how well the company is positioned to perform in the future. Although Safeplus International's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company was founded in 1963 and is based in Pittsford, New York. BIOPHAN TECHNOLOGIES operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
When determining whether Safeplus International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Safeplus International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Safeplus International Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Safeplus International Holdings Stock:Check out the analysis of Safeplus International Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Safeplus International. If investors know Safeplus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Safeplus International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Safeplus International is measured differently than its book value, which is the value of Safeplus that is recorded on the company's balance sheet. Investors also form their own opinion of Safeplus International's value that differs from its market value or its book value, called intrinsic value, which is Safeplus International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Safeplus International's market value can be influenced by many factors that don't directly affect Safeplus International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Safeplus International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Safeplus International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Safeplus International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.